Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

SZSE:002864 Stok Raporu

Piyasa değeri: CN¥2.9b

Shaanxi Panlong Pharmaceutical Group Limited By Share Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Shaanxi Panlong Pharmaceutical Group Limited By Share.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi19.3%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Sep 30
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Mar 06
Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Shaanxi Panlong Pharmaceutical Group Limited By Share yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SZSE:002864 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/202498211677150N/A
6/30/202493611679156N/A
3/31/202496512096166N/A
12/31/202398111042104N/A
9/30/20239971074393N/A
6/30/20231,04311166113N/A
3/31/20231,0011033387N/A
1/1/202397410170125N/A
9/30/20229589877149N/A
6/30/20229179673151N/A
3/31/20229119668151N/A
1/1/20228879335116N/A
9/30/20218428646136N/A
6/30/20218348928114N/A
3/31/202176487-276N/A
12/31/2020670792192N/A
9/30/202062680572N/A
6/30/202056566-152N/A
3/31/2020571703879N/A
12/31/2019611723468N/A
9/30/2019587763557N/A
6/30/2019564724161N/A
3/31/2019516673353N/A
12/31/2018489652747N/A
9/30/2018442572236N/A
6/30/201842456N/A22N/A
3/31/201840446N/A30N/A
12/31/201737744N/A28N/A
9/30/201736949N/A41N/A
6/30/201733344N/A62N/A
3/31/201730540N/A52N/A
12/31/201630540N/A62N/A
12/31/201525643N/A41N/A
12/31/201424640N/A49N/A
12/31/201322733N/A25N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if 002864's forecast earnings growth is above the savings rate (2.9%).

Kazançlar ve Piyasa: Insufficient data to determine if 002864's earnings are forecast to grow faster than the CN market

Yüksek Büyüme Kazançları: Insufficient data to determine if 002864's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if 002864's revenue is forecast to grow faster than the CN market.

Yüksek Büyüme Geliri: Insufficient data to determine if 002864's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if 002864's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin